July 8 , 2022 | Events
Repigment12 and its optimal results are presented at the III Ibero-Latin American Congress of Dermatology
Bella Aurora Laboratories, together with Dr. Matteo Bordignon, an Italian dermatologist specializing in vitiligo, participated in the III Ibero Latin American Dermatology Congress held in Madrid from June 30th to July 3rd.
Dr. Bordignon presented the lecture "MIA Inhibitors technology in the treatment of vitiligo" as part of the TOP 10 Industry Innovations sessions.
Repigment12 was launched in May 2021 as Bella Aurora Laboratories' first cosmetic treatment for white spots, and since then, it has been achieving great results that were presented at this dermatological event.
Under the motto "All under the same skin," more than 5,000 professionals from over 20 countries in Spain, Portugal, and Latin America attended this congress, which CILAD has been organizing for three editions and served to strengthen Bella Aurora's leadership in innovation and research on skin pigmentation.
RELATED NEWS
